Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CNTX-4975-05 regimen comfort and ease-of-use study in knee osteoarthritis
2018-003094-10Phase 3Completed
- Sponsor
- Centrexion Therapeutics
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of capsaicin in knee osteoarthritis (OA) (5 arms), sponsored by Centrexion Therapeutics. Primary endpoint: Primary combined treatment regimen assessment. Started Aug 2018; status: completed.
02
Drugs
capsaicin
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2018-003094-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003094-10.